A pleuromutilin–ciprofloxacin hybrid exhibits potent activity against Streptococcus suis
The emergence and dissemination of antimicrobial resistance in Streptococcus suis, an important zoonotic pathogen, have created an urgent demand for new therapeutic agents with improved antibacterial efficacy. To address this challenge, we previously designed and synthesized a novel hybrid molecule, PHC, by linking cip...